Dr Dianne Webster has directed the national newborn metabolic screening programme (NMSP) for more than 25 years. The programme detects 50 to 60 affected babies annually, many of whom would have died or suffered life-long disabilities if their condition had not been detected.
She has held several panel and leadership roles with the Clinical and Laboratory Standards Institute (USA). She chairs the newborn screening subcommittee of the Human Genetics Society of Australasia and has supported screening initiatives in many other countries.
She is the Secretary of the Australasian Society for Inborn Errors of Metabolism and the Vice-President and an Asia-Pacific representative on the Council of the International Society for Neonatal Screening (ISNS).
Dr Webster recently served on the organising committee for the 10th International ISNS meeting, held in Hangzhou, China.